Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

2WBA

Properties of Trypanothione Reductase From T. brucei

Replaces:  2VE2
Summary for 2WBA
Entry DOI10.2210/pdb2wba/pdb
DescriptorTRYPANOTHIONE REDUCTASE, FLAVIN-ADENINE DINUCLEOTIDE, GLYCEROL, ... (7 entities in total)
Functional Keywordsredox-active center, flavoprotein, trypnothione metabolism oxidoreductase, oxidoreductase
Biological sourceTRYPANOSOMA BRUCEI BRUCEI
Total number of polymer chains2
Total formula weight110616.42
Authors
Jones, D.,Ariza, A.,Chow, W.H.A.,Oza, S.L.,Fairlamb, A.H. (deposition date: 2009-02-24, release date: 2009-11-24, Last modification date: 2024-11-20)
Primary citationJones, D.,Ariza, A.,Chow, W.H.A.,Oza, S.L.,Fairlamb, A.H.
Comparative Structural, Kinetic and Inhibitor Studies of Trypanosoma Brucei Trypanothione Reductase with T. Cruzi.
Mol.Biochem.Parasitol., 169:12-, 2010
Cited by
PubMed Abstract: As part of a drug discovery programme to discover new treatments for human African trypanosomiasis, recombinant trypanothione reductase from Trypanosoma brucei has been expressed, purified and characterized. The crystal structure was solved by molecular replacement to a resolution of 2.3A and found to be nearly identical to the T. cruzi enzyme (root mean square deviation 0.6A over 482 Calpha atoms). Kinetically, the K(m) for trypanothione disulphide for the T. brucei enzyme was 4.4-fold lower than for T. cruzi measured by either direct (NADPH oxidation) or DTNB-coupled assay. The K(m) for NADPH for the T. brucei enzyme was found to be 0.77microM using an NADPH-regenerating system coupled to reduction of DTNB. Both enzymes were assayed for inhibition at their respective S=K(m) values for trypanothione disulphide using a range of chemotypes, including CNS-active drugs such as clomipramine, trifluoperazine, thioridazine and citalopram. The relative IC(50) values for the two enzymes were found to vary by no more than 3-fold. Thus trypanothione reductases from these species are highly similar in all aspects, indicating that they may be used interchangeably for structure-based inhibitor design and high-throughput screening.
PubMed: 19747949
DOI: 10.1016/J.MOLBIOPARA.2009.09.002
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.3 Å)
Structure validation

247035

PDB entries from 2026-01-07

PDB statisticsPDBj update infoContact PDBjnumon